Vulnerability in N/a
CVE-2025-50675
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS 0.003, 18.5th percentile (last changed ); unchanged over 30 days. About EPSS.
Weakness classification (CWE)
Public exploits and proof-of-concept code
1 public repository with exploit or proof-of-concept code for this CVE:
- LukeSec/CVE-2025-50675-GPMAW-Permissions (last pushed 2025-08-05): CVE-2025-50675: Insecure install folder permissions in GPMAW bioinformatics software
Also mentioned in 3 other repositories (fkie-cad/nvd-json-data-feeds, nomi-sec/PoC-in-GitHub, yembors64632/cve_monitor_Public). These reference the CVE in a list, notes or a scanner and are not exploit code for it.
References
This CVE has public exploit evidence. See the latest CVEs with public exploits.